Business Description
Biocytogen Pharmaceuticals (Beijing) Co Ltd
ISIN : CNE100005D27
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.75 | |||||
Equity-to-Asset | 0.32 | |||||
Debt-to-Equity | 0.69 | |||||
Debt-to-EBITDA | -1.94 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 1.18 | |||||
Beneish M-Score | -2.79 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 37.5 | |||||
3-Year EBITDA Growth Rate | 39.7 | |||||
3-Year EPS without NRI Growth Rate | -0.1 | |||||
3-Year FCF Growth Rate | 29.4 | |||||
3-Year Book Growth Rate | -20.8 | |||||
Future 3-5Y Total Revenue Growth Rate | 23.99 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61.49 | |||||
9-Day RSI | 63.9 | |||||
14-Day RSI | 61.71 | |||||
6-1 Month Momentum % | -49.15 | |||||
12-1 Month Momentum % | -73.44 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.25 | |||||
Quick Ratio | 1.1 | |||||
Cash Ratio | 0.71 | |||||
Days Inventory | 160.06 | |||||
Days Sales Outstanding | 62.28 | |||||
Days Payable | 259.27 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -3.42 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 70.59 | |||||
Operating Margin % | -42.69 | |||||
Net Margin % | -53.42 | |||||
FCF Margin % | -28.35 | |||||
ROE % | -39.39 | |||||
ROA % | -14.31 | |||||
ROIC % | -14.6 | |||||
ROC (Joel Greenblatt) % | -17.99 | |||||
ROCE % | -13.61 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4.84 | |||||
PB Ratio | 4.43 | |||||
Price-to-Tangible-Book | 4.6 | |||||
EV-to-EBIT | -22.34 | |||||
EV-to-Forward-EBIT | -170.68 | |||||
EV-to-EBITDA | -22.34 | |||||
EV-to-Revenue | 8.74 | |||||
EV-to-Forward-Revenue | 7.55 | |||||
EV-to-FCF | -30.78 | |||||
Earnings Yield (Greenblatt) % | -4.48 | |||||
FCF Yield % | -3.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Biocytogen Pharmaceuticals (Beijing) Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 784.144 | ||
EPS (TTM) (HK$) | -1.05 | ||
Beta | 0 | ||
Volatility % | 29.52 | ||
14-Day RSI | 61.71 | ||
14-Day ATR (HK$) | 0.631329 | ||
20-Day SMA (HK$) | 8.446 | ||
12-1 Month Momentum % | -73.44 | ||
52-Week Range (HK$) | 5.74 - 25 | ||
Shares Outstanding (Mil) | 398.25 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Biocytogen Pharmaceuticals (Beijing) Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Biocytogen Pharmaceuticals (Beijing) Co Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Biocytogen Pharmaceuticals (Beijing) Co Ltd Frequently Asked Questions
What is Biocytogen Pharmaceuticals (Beijing) Co Ltd(HKSE:02315)'s stock price today?
When is next earnings date of Biocytogen Pharmaceuticals (Beijing) Co Ltd(HKSE:02315)?
Does Biocytogen Pharmaceuticals (Beijing) Co Ltd(HKSE:02315) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |